Compare CNTB & USGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNTB | USGO |
|---|---|---|
| Founded | 2012 | 2015 |
| Country | United States | United States |
| Employees | N/A | 10 |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 135.7M | 112.8M |
| IPO Year | 2020 | N/A |
| Metric | CNTB | USGO |
|---|---|---|
| Price | $1.97 | $8.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $8.67 | ★ $30.75 |
| AVG Volume (30 Days) | ★ 302.6K | 53.9K |
| Earning Date | 08-13-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $64,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.23 | $7.42 |
| 52 Week High | $3.82 | $17.98 |
| Indicator | CNTB | USGO |
|---|---|---|
| Relative Strength Index (RSI) | 37.41 | 33.65 |
| Support Level | $1.46 | $7.55 |
| Resistance Level | $2.05 | $9.80 |
| Average True Range (ATR) | 0.19 | 0.62 |
| MACD | -0.01 | 0.07 |
| Stochastic Oscillator | 11.71 | 33.11 |
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.
US Goldmining Inc is a mineral exploration company with a focus on the exploration and development of a project located in Alaska, USA. The company's primary asset is the 100%-owned Whistler exploration property located in Alaska, USA. It operates and reports in one segment, which focuses on the exploration and development of mineral properties.